Medicinal mushroom: boon for therapeutic applications
Vivek K. Chaturvedi,Sonam Agarwal,Krishna Kumar Gupta,Pramod W. Ramteke,Mohan Singh +4 more
- Vol. 8, Iss: 8, pp 334-334
TLDR
The present review focuses on the comprehensive account of the medicinal properties of various medicinal mushrooms, which will further help the researchers to understand the metabolites and find other metabolites from the mushrooms which can be used for the potential development of the drugs to treat various life-threatening diseases.Abstract:
Medicinal mushrooms are higher fungi with additional nutraceutical attributes having low fat content and a trans-isomer of unsaturated fatty acids along with high fibre content, triterpenes, phenolic compounds, sterols, eritadenine and chitosan. They are considered as the unmatched source of healthy foods and drugs. They have outstanding attractive taste, aroma and nutritional value, so are considered as functional food, which means they are beneficial to the body not only in terms of nutrition but also for improved health. Medicinal mushrooms and their extract have a large number of bioactive components called secondary metabolites. The presence of polysaccharide β-glucans or polysaccharide–protein complexes content in mushroom extract have great therapeutic applications in human health as they possess many properties such as anti-diabetic, anti-cancerous, anti-obesity, immunomodulatory, hypocholesteremia, hepatoprotective nature along with anti-aging. The present review focuses on the comprehensive account of the medicinal properties of various medicinal mushrooms. This will further help the researchers to understand the metabolites and find other metabolites as well from the mushrooms which can be used for the potential development of the drugs to treat various life-threatening diseases.read more
Citations
More filters
Journal ArticleDOI
The biology of ergothioneine, an antioxidant nutraceutical.
Irina Borodina,Louise C. Kenny,Cathal McCarthy,Kalaivani Paramasivan,Etheresia Pretorius,Timothy J. Roberts,Timothy J. Roberts,Steven Axel van der Hoek,Douglas B. Kell,Douglas B. Kell,Douglas B. Kell +10 more
TL;DR: Mushroom or ERG consumption seems to provide significant prevention against oxidative stress in a large variety of systems, and it may have value as a nutraceutical and antioxidant more generally.
Journal ArticleDOI
Current Prospects of Nutraceuticals: A Review.
TL;DR: An overview of various bioactive ingredients which act as nutraceuticals (carbohydrates, lipids, edible flowers, alkaloids, medicinal plants, etc.) and their role in health benefits has been discussed and further application of nutr pharmaceuticals in various diseases prevention has been also discussed.
Journal ArticleDOI
Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
TL;DR: The molecular mechanisms that come from other than HBV endemic places which can be innovative approaches to treat HCC are outlined.
Journal ArticleDOI
Immunomodulatory Effects of Edible and Medicinal Mushrooms and Their Bioactive Immunoregulatory Products.
TL;DR: The current status of clinical studies on immunomodulatory activities of mushrooms and mushroom products are reviewed and the approaches that have been used in the development and application of bioactive compounds extracted from mushrooms are described.
Journal ArticleDOI
Edible Mushrooms as Functional Ingredients for Development of Healthier and More Sustainable Muscle Foods: A Flexitarian Approach.
Arun K. Das,P. K. Nanda,Premanshu Dandapat,Samiran Bandyopadhyay,Patricia Gullón,G.K. Sivaraman,David Julian McClements,Beatriz Gullón,José M. Lorenzo +8 more
TL;DR: In this article, the effects of functional ingredients of mushrooms in improving the quality and sensory attributes of nutritionally superior and next-generation healthier muscle food products are also highlighted in this paper.
References
More filters
Journal ArticleDOI
Anti-inflammatory effects of five commercially available mushroom species determined in lipopolysaccharide and interferon-γ activated murine macrophages.
Dhanushka Gunawardena,Louise E. Bennett,Kirubakaran Shanmugam,Kerryn King,Roderick P.W. Williams,Dimitrios Zabaras,Richard Head,Lezanne Ooi,Erika Gyengesi,Gerald Münch +9 more
TL;DR: In this paper, the anti-inflammatory activity of Oyster mushrooms was investigated in lipopolysaccharide (LPS) and interferon-γ (IFN-γ) activated murine RAW 264.7 macrophages.
Journal ArticleDOI
Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum.
Ichiko Miyamoto,Jie Liu,Kuniyoshi Shimizu,Masao Sato,Akiko Kukita,Toshio Kukita,Ryuichiro Kondo +6 more
TL;DR: The preventative effects of the ethanol extracts of Ganoderma lucidum against the ovariectomized (Ovx)-induced deterioration of bone density in 11-week-old female Sprague Dawley (SD) rats were investigated and the results showed that the G. lucidum-treated Ovx rats showed improved bone density compared with the Ovx Rats.
Journal ArticleDOI
Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G2/M cell cycle arrest
Shih Chung Hsu,Chien Chih Ou,Jhy Wei Li,Tzu-Chao Chuang,Han Pin Kuo,Jah Yao Liu,Chin Shiang Chen,Song Chow Lin,Ching-Hua Su,Ming-Ching Kao,Ming-Ching Kao +10 more
TL;DR: Molecular evidence is provided that Ganoderma tsugae extracts exert anti-tumor effects both in vitro and in vivo on colorectal adenocarcinoma cells by inducing G(2)/M cell cycle arrest.
Journal ArticleDOI
Variation of the antimutagenicity effects of water extracts of Agaricus blazei Murrill in vitro.
Z.R. Guterrez,Mário Sérgio Mantovani,Augusto Ferreira da Eira,Lúcia Regina Ribeiro,Berenice Quinzani Jordão +4 more
TL;DR: This work evaluated the mutagenic and antimutagenic potential from aqueous extracts prepared in different temperatures from the lineage AB 97/29 in two basidiocarp phases (young and sporulated) and from A. blazei commercialized in Londrina-PR- Brazil, named here as AB PR, and in Piedade-SP-Brazil, named as AB SP.
Journal ArticleDOI
Evaluation of antidiabetic activity of polysaccharide isolated from Phellinus linteus in non-obese diabetic mouse.
Hwan Mook Kim,Jong Soon Kang,Jee Youn Kim,Song-Kyu Park,Hyung Sook Kim,Young June Lee,Jieun Yun,Jin Tae Hong,Youngsoo Kim,Sang-Bae Han +9 more
TL;DR: It is reported that PLP can inhibit the development of autoimmune diabetes in non-obese diabetic (NOD) mice and regulating cytokine expression is suggested.